Condition
Asthma Attack
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 27 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
27 shownBoosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma ExacerbationNCT07396987 · 2026-07-19
RECRUITINGPost Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent ExacerbationsNCT07629830 · 2026-07-01
RECRUITINGCost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma MorbidityNCT07116460 · 2026-01-30
RECRUITINGRemote Monitoring of Asthma in Children and Young PeopleNCT07129616 · 2025-11-20
RECRUITINGIndividualizing Treatment for Asthma in Primary Care (Full Study)NCT07052942 · 2025-08-01
RECRUITINGRemote Patient Monitoring Solution for Chronic Respiratory Disease ManagementNCT06377345 · 2024-05-01
RECRUITINGTimely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma ExacerbationNCT06137040 · 2023-11-30
RECRUITINGNebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma ExacerbationsNCT07112456 · 2026-09-01
NOT_YET_RECRUITINGPragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma ExacerbationsNCT03277170 · 2025-09-01
WITHDRAWNWearable Electronic Breath Sound Sensing DeviceNCT06734793 · 2025-02-26
COMPLETEDThe Effect of Asthma Flare-up Clinic After ExacerbationNCT06201728 · 2024-05-01
ACTIVE_NOT_RECRUITINGThe Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of AsthmaNCT05603494 · 2023-03-29
UNKNOWNA Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic AsthmaNCT05748600 · 2023-01-30
ACTIVE_NOT_RECRUITINGPhenotyping and Classifying Asthma ExacerbationsNCT05304039 · 2022-09-28
ACTIVE_NOT_RECRUITINGUsing the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma ExacerbationsNCT05417906 · 2022-06-02
UNKNOWNAsthma: Phenotyping Exacerbations 3NCT05446090 · 2022-05-09
UNKNOWNOptimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)NCT04941001 · 2021-08-09
COMPLETEDBenralizumab Initiated During Severe Asthma AttackNCT04617171 · 2021-06-02
UNKNOWNASTHMAXcel Emergency Department StudyNCT05013073 · 2021-05-01
TERMINATEDImpact of Asthma ExacerbationsNCT04410120 · 2020-09-01
UNKNOWNThe Effect of Nebulization Positions in Asthmatic ChildrenNCT05318885 · 2019-10-15
COMPLETEDEvaluating Asthma Exacerbation-induced Changes in Lung Function With a Home-based SpirometerNCT03705325 · 2019-02-22
COMPLETEDNebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma ExacerbationNCT05908864 · 2018-10-30
COMPLETEDChild Asthma : What Parents Attitude During an Asthma Attack at Home Before Consulting the Pediatric EmergenciesNCT03967873 · 2018-10-09
COMPLETEDUser-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma PatientsNCT03642418 · 2018-08-13
COMPLETEDGenomics and Metagenomics of Asthma SeverityNCT04501926 · 2018-03-01
UNKNOWNAsthma Attack in the Emergency Department : Reasons Of This AttendanceNCT03099915 · 2017-03-17
COMPLETEDCommon interventions
A Randomized Controlled StudyOTHER1Acute Asthma Quality of Life QuestionnaireOTHER1AeviceMD deviceDEVICE1Asthma Symptom Monitoring Web-based ApplicationOTHER1ASTHMAXcel ED ApplicationOTHER1Austin Air CleanerDEVICE1AzithromycinDRUG1Benralizumab 30 MG/ML [Fasenra]DRUG1Blood samplePROCEDURE1BloodsDIAGNOSTIC_TEST1completion of self-reported questionnairesOTHER1Compliance and adherenceOTHER1Corsano watchDEVICE1Dexpramipexole DihydrochlorideDRUG1e-NoseDEVICE1Eosinophil-directed careOTHER1ER-Initiated Telehealth ReferralBEHAVIORAL1Follow-up in a flare-up clinicOTHER1Follow-up in a remote flare-up clinicOTHER1Forced Oscillation Technique (FOT)DIAGNOSTIC_TEST1Fractional Exhaled Nitric Oxide (FeNO)DEVICE1Fractional Exhaled Nitric Oxide (FeNO)DIAGNOSTIC_TEST1Gastroesophageal Reflux Disease QuestionnaireOTHER1Hospital Anxiety and Depression ScaleOTHER1Inhaled corticosteroid (ICS)DRUG1
Leading sponsors
Tel-Aviv Sourasky Medical Center
2
University of Nottingham
2
Areteia Therapeutics
1
Beni-Suef University
1
Chang Gung Memorial Hospital
1
Changi General Hospital
1
Columbia University
1
DARTNet Institute
1
Emory University
1
Franciscus Gasthuis
1
Guy's and St Thomas' NHS Foundation Trust
1
Istanbul University - Cerrahpasa
1
Juan Carlos Cardet
1
Maria Pino-Yanes
1
Montefiore Medical Center
1
Trial status mix
COMPLETED8
RECRUITING7
UNKNOWN6
ACTIVE_NOT_RECRUITING3
NOT_YET_RECRUITING1
TERMINATED1
WITHDRAWN1
Phase mix
NA10
PHASE24
EARLY_PHASE11
PHASE31
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.